Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL301318

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1cc(Cn2cc(C(=O)C(=O)Nc3cc(C)ns3)c3ccccc32)on1

Basic Information

ChEMBL ID CHEMBL301318
Phase Preclinical
Structure Type MOL
InChI Key NCACNRXZERQYMR-UHFFFAOYSA-N
7
Targets
19
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names

Molecular Properties

380.4
MW (Da)
3.57
ALogP
7
HBA
1
HBD
90.0
PSA (Ų)
0.42
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C19H16N4O3S
MW 380.43
Aromatic Rings 4
Heavy Atoms 27
NP-Likeness -1.94

Activity Summary

IC50 19 meas. best 8.52

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
NON-PROTEIN TARGET
CHEMBL3879801
IC50 8.52 7.0017 3.0 12
MES-SA/Dx5
CHEMBL613827
IC50 7.77 7.745 17.0 2
P388
CHEMBL389
IC50 7.75 7.75 18.0 1
MCF7
CHEMBL387
IC50 7.48 7.48 33.0 1
NUGC-3
CHEMBL614208
IC50 7.2 7.2 63.0 1
MCF7S
CHEMBL614328
IC50 7.14 7.14 73.0 1
HepG2
CHEMBL395
IC50 5.77 5.77 1711.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
NON-PROTEIN TARGET IC50 = 3.0 nM 8.52 Cytotoxicity against human HONE1 cells assessed as reduction in cell growth afte... -
NON-PROTEIN TARGET IC50 = 8.0 nM 8.1 Cytotoxicity against human HR cells assessed as reduction in cell growth after 7... -
NON-PROTEIN TARGET IC50 = 12.0 nM 7.92 Cytotoxicity against human NUGC3 cells assessed as reduction in cell growth afte... -
MES-SA/Dx5 IC50 = 17.0 nM 7.77 In vitro anticancer activity against human uterus MES-SA/Dx5 subline (doxorubici... 12699388
P388 IC50 = 18.0 nM 7.75 In vitro anticancer activity against murine leukemic P388 cells 12699388
MES-SA/Dx5 IC50 = 19.0 nM 7.72 In vitro anticancer activity against human uterus MES-SA cells 12699388
MCF7 IC50 = 33.0 nM 7.48 In vitro anticancer activity against human breast MCF-7/ADR subline (adriamycin-... 12699388
NON-PROTEIN TARGET IC50 = 36.0 nM 7.44 Cytotoxicity against human MCF7 cells assessed as reduction in cell growth after... -
NON-PROTEIN TARGET IC50 = 41.0 nM 7.39 Cytotoxicity against human DLD1 cells assessed as reduction in cell growth after... -
NUGC-3 IC50 = 63.0 nM 7.2 In vitro anticancer activity against human gastric NUGC3 cells 12699388
MCF7S IC50 = 73.0 nM 7.14 In vitro anticancer activity against human breast MCF-7 cells 12699388
NON-PROTEIN TARGET IC50 = 93.0 nM 7.03 Cytotoxicity against human HepG2 cells assessed as reduction in cell growth afte... -
NON-PROTEIN TARGET IC50 = 123.0 nM 6.91 Cytotoxicity against human HA22T cells assessed as reduction in cell growth afte... -
NON-PROTEIN TARGET IC50 = 293.0 nM 6.53 Cytotoxicity against human MES-SA cells assessed as reduction in cell growth aft... -
NON-PROTEIN TARGET IC50 = 368.0 nM 6.43 Cytotoxicity against human MES-SA/Dx5 cells assessed as reduction in cell growth... -
NON-PROTEIN TARGET IC50 = 557.0 nM 6.25 Cytotoxicity against human A549 cells assessed as reduction in cell growth after... -
NON-PROTEIN TARGET IC50 = 628.0 nM 6.2 Cytotoxicity against human PC3 cells assessed as reduction in cell growth after ... -
HepG2 IC50 = 1711.0 nM 5.77 In vitro anticancer activity against human hepatocellular HepG2 cells 12699388
NON-PROTEIN TARGET IC50 = 5004.0 nM 5.3 Cytotoxicity against human MCF7/ADR cells assessed as reduction in cell growth a... -

Literature References

PubMed DOI Target Context # Activities
12699388 10.1021/jm020471r Mus musculus 4
12699388 10.1021/jm020471r MES-SA/Dx5 2
12699388 10.1021/jm020471r No relevant target 1
12699388 10.1021/jm020471r NUGC-3 1
12699388 10.1021/jm020471r HepG2 1
12699388 10.1021/jm020471r MCF7S 1
12699388 10.1021/jm020471r MCF7 1
12699388 10.1021/jm020471r P388 1

Data from ChEMBL 36 via Core Engine